Through in vivo and in vitro experimental analysis, we proved that NEU1 inhibition promotes the biogenesis and function of mitochondria by enhancing the SIRT1/PGC-1α signaling pathway, thereby improving poor myocardial remodeling after MI. Here, PPARGC1A is linked to myocardial infarction.